新型冠状病毒肺炎临床合理用药专家共识

Expert consensus on rational drug use in clinical practice for COVID-19

新型冠状病毒肺炎(coronavirus disease 2019,COVID-19)疫情发生以来,全国医院药学工作者坚持医药协同,在保障药品供应的前提下,积极参与临床救治工作,加强对患者的用药教育和指导,有效提高药物治疗水平,改善临床救治效果。为更好地发挥药学服务在COVID-19疫情防控中的重要作用,中国药学会医院药学专业委员会特组织临床和药学专家,在《新型冠状病毒感染的肺炎诊疗方案(试行第七版)》的基础上,参考国内外最新的诊疗方案和研究成果,并结合国内各地COVID-19患者的救治经验,制定出新型冠状病毒肺炎临床合理用药专家共识。本共识详细阐述COVID-19临床救治的九类用药,内容涵盖药物治疗作用、遴选原则、用法用量、不良反应及注意事项,以期为COVID-19临床用药提供参考。

Since the outbreak of the corona virus disease 2019(COVID-19),pharmacists in Chinese hospitals have been adhering to the principle of aligning medication with clinical needs,actively participating in clinical treatment under the premise of ensuring medicine supply,enhancing medication education and guidance for patients,and achieving effective improvement in medication efficacy and clinical results.In order to provide better services in the prevention and control of the pandemic,based on the Diagnosis and Treatment Plan for COVID-19(the 7th Tentative Version)issued by the National Health Commission of the People’s Republic of China and review of the latest diagnosis and treatment plans and the latest research findings,and also combined with real-world experiences in various provinces in China,experts from the Hospital Pharmacy Professional Committee of the Chinese Pharmaceutical Association compiled the Expert Consensus on Rational Drug Use in Clinical Practice for COVID-19.The full text is divided into 9 parts,categorizing and explaining COVID-19’s clinical treatment,including therapeutic efficacy,selection principles,uses and doses,adverse reactions and precautions of medicines,which can provide a good reference for clinical medication for COVID-19.